CPH creso pharma limited

Ann: Preliminary Report & Annual Report to shareholders, page-7

  1. 26,915 Posts.
    lightbulb Created with Sketch. 1314
    agree, this is what we discussed last quarter.

    but, human and animal derived revenue is up over 550% in 1 year.
    this revenue is very much going in the right direction very quickly

    they did mention last quarter that they intended to slash costs, and that isn't showing up at present.

    if I was a shareholder in for the longer term, I would put substantial pressure on them to address cost reductions as they have said "

    if they did that, and revenue kept growing at these levels or close to , you have a good business starting to emerge.

    keep ramping up revenue, but ramp costs down at same time.

    obviously they will be looking at cutting quite a few staff numbers, and sales go to incentive payments etc as previously discussed.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.